BIOMEDICA CROBIOMEDICA CRO
  • +38 (068) 150 70 04
  • office@biomedica-cro.com
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • ENEN
    • UAUA
Search
SEND REQUEST
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • Home
  • Blog
  • Banked biospecimens for cancer & other diseases research | BIOMEDICA CRO

Banked biospecimens for cancer & other diseases research | BIOMEDICA CRO

Banked biospecimens for cancer & other diseases research | BIOMEDICA CRO

05.09.2023
BIOMEDICA CRO - order high-quality banked biospecimens and associated clinical data: FFPE blocks, frozen tissues, whole blood, plasma, serum, buffy coat, PBMC, etc.
admin2024-04-02T19:16:50+00:00

Innovative approaches in drug discovery against cancer – the latest scientific article review by BIOMEDICA CRO team 💊

Scientists are utilizing peptide stapling and fragment-based drug discovery in their innovative approaches to fighting cancer. These methods specifically target the cancer-causing proteins that drive the disease.

By focusing on proteins called BCL-2 that are crucial for cancer growth, these technologies show promise in developing effective treatments for human cancer.
Using peptide stapling, scientists can stabilize peptides that specifically target BCL-2. By introducing cross-links or ‘staples’ to the peptide, its structure is enhanced, making it more stable and resistant to degradation. This stapled peptide can effectively bind to BCL-2.

Fighting cancer through targeted drug treatments is a promising approach. Scientists have studied cancer biology in detail and identified specific targets for more effective and personalized treatments. Despite ongoing challenges, continuous research and collaboration provide optimism for progress in cancer therapeutics.

Banked biospecimens: Blood and FFPE Blocks for cancer & other diseases research 🎗

At BIOMEDICA CRO, we routinely collect hundreds of human biospecimens with valuable and precise clinical data for pharmaceutical companies and diagnostic centers. We manage our own network of 50+ direct contracts with hospitals in Ukraine in many disease areas and are always ready to make a new one if necessary.

Our main area is Oncology and the study of the following conditions:

  • Lung cancer;
  • Breast cancer;
  • Colorectal cancer;
  • Prostate cancer;
  • Kidney cancer;
  • Head & Neck cancer, etc.

We mainly focus on the prospective customized studies, but we also acknowledge that having banked biospecimens already collected, stored and available for use allows certain research studies to be performed quicker and easier.
Thus, we offer a wide range of specimens, including FFPE blocks, frozen tissues, whole blood, plasma, serum, buffy coat, rest blood, PBMC, urine, saliva, and more.

Moreover, you can find numerous matched biosample sets, containing matched tissue in FFPE blocks, fresh frozen tissue specimens and biofluids obtained from the same donor. All these biospecimens are collected from diverse patient populations and are carefully processed and stored to maintain their integrity and usability for research purposes.

🌐 Visit our “Inventory” section to review the list of available-to-order samples now by clicking here.

📩 Please let us know what we can book for you today by contacting us through email at office@biomedica-cro.com.
Don’t see what you need in our current Inventory? Feel free to send the requirements for biospecimens you are looking for, and we will happily re-check our Inventory or create a proposal for the prospective collection for your review. We are here to help!

🚀 Follow us on LinkedIn social media to stay up-to-date with the latest advancements, industry news, and exclusive offers in the field of biospecimen procurement. Together, let’s drive innovation and make remarkable discoveries.

Feel free to place a request for human biospecimens.

Share this post

Facebook Twitter LinkedIn
All publications
’Quality is our DNA’ principle – an integral part of BIOMEDICA CRO in biospecimens collection & project management
Human tissue & biofluid samples for Inflammatory Bowel Disease (IBD) research
  • Biospecimens
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts

Privacy Policy | Terms of use

Linkedin

Site development mamontova design

BIOMEDICA CRO
© 2021 | All rights reserved

View the Inventory

Click on the button "Download the inventory" to review the list of ready-to-ship biospecimens.

Download the Inventory

Iryna Iurkova

Business Development Director

Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.

Serhii Samsoniuk

Chief Executive Officer

Mr. Samsoniuk is a pharmaceutical expert with over 15 years of industry experience. Over the course of his career, he has held key leadership roles at both international and local companies, such as GlaxoSmithKline, B.Braun, and Sona Exim, overseeing strategic marketing, sales, and key account management. Before joining BIOMEDICA CRO team, he led business development efforts in the CCA+ region at Farmak, driven by a commitment to professional ethics and strategic partnership.

Anton Zubov - MD, BIOMEDICA CRO Co-Founder, Board Member

Anton Zubov

MD, BIOMEDICA CRO Co-Founder,
Board Member

Dr. Zubov has over 21 years of experience in the international pharmaceutical markets. He has held numerous leading positions in marketing, management and sales at Schering AG and Bayer Pharmaceuticals. He has made a career internationally with positions in Ukraine, Germany and Central Asia. In 2017, together with Dr. Kupnovitsky, he founded BIOMEDICA CRO and during the first years was its CINO. Dr. Zubov is currently a Marketing & Sales Director of the CIS Region in Farmak and Board Member of BIOMEDICA CRO Supervisory Board.

have any questions?

Send request

Fill out the form and we will contact you shortly

    Name

    E-mail

    Your message


    have any questions?

    Send request

    Please send us a message and we’ll be back to you shortly

      Name

      Company name

      E-mail

      Your message

      Ostap Kupnovitsky - PhD, MD, MBA, BIOMEDICA CRO Co-Founder, Chairman of the Supervisory Board

      Ostap Kupnovitsky

      PhD, MD, MBA,
      BIOMEDICA CRO Co-Founder,
      Chairman of the Supervisory Board

      Dr. Kupnovitsky has a vast experience in the pharmaceutical market. He was the Regional Director of Organon and Serono in Ukraine. In 2003, he became a Co-Founder and Director of Sona-Pharm, the firm that started its activity in Ukraine and has flourished into an international marketing company with its representatives throughout the CIS region. Since 2017, when BIOMEDICA CRO was founded, he has been a distinguished Chairman of its Supervisory Board.